Chapter/Section Purchase

1 Study Coverage
1.1 Oral Proteins and Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Linaclotide
1.2.3 Calcitonin
1.2.4 Insulin
1.2.5 Octreotide
1.3 Market by Application
1.3.1 Global Oral Proteins and Peptides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Proteins and Peptides Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Proteins and Peptides Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Proteins and Peptides Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Proteins and Peptides Sales by Region
2.4.1 Global Oral Proteins and Peptides Sales by Region (2017-2022)
2.4.2 Global Sales Oral Proteins and Peptides by Region (2023-2028)
2.5 Global Oral Proteins and Peptides Revenue by Region
2.5.1 Global Oral Proteins and Peptides Revenue by Region (2017-2022)
2.5.2 Global Oral Proteins and Peptides Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Proteins and Peptides Sales by Manufacturers
3.1.1 Global Top Oral Proteins and Peptides Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Proteins and Peptides in 2021
3.2 Global Oral Proteins and Peptides Revenue by Manufacturers
3.2.1 Global Oral Proteins and Peptides Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Proteins and Peptides Revenue in 2021
3.3 Global Oral Proteins and Peptides Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Proteins and Peptides Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Proteins and Peptides Sales by Type
4.1.1 Global Oral Proteins and Peptides Historical Sales by Type (2017-2022)
4.1.2 Global Oral Proteins and Peptides Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Proteins and Peptides Sales Market Share by Type (2017-2028)
4.2 Global Oral Proteins and Peptides Revenue by Type
4.2.1 Global Oral Proteins and Peptides Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Proteins and Peptides Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Proteins and Peptides Revenue Market Share by Type (2017-2028)
4.3 Global Oral Proteins and Peptides Price by Type
4.3.1 Global Oral Proteins and Peptides Price by Type (2017-2022)
4.3.2 Global Oral Proteins and Peptides Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Proteins and Peptides Sales by Application
5.1.1 Global Oral Proteins and Peptides Historical Sales by Application (2017-2022)
5.1.2 Global Oral Proteins and Peptides Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Proteins and Peptides Sales Market Share by Application (2017-2028)
5.2 Global Oral Proteins and Peptides Revenue by Application
5.2.1 Global Oral Proteins and Peptides Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Proteins and Peptides Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Proteins and Peptides Revenue Market Share by Application (2017-2028)
5.3 Global Oral Proteins and Peptides Price by Application
5.3.1 Global Oral Proteins and Peptides Price by Application (2017-2022)
5.3.2 Global Oral Proteins and Peptides Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Proteins and Peptides Market Size by Type
6.1.1 North America Oral Proteins and Peptides Sales by Type (2017-2028)
6.1.2 North America Oral Proteins and Peptides Revenue by Type (2017-2028)
6.2 North America Oral Proteins and Peptides Market Size by Application
6.2.1 North America Oral Proteins and Peptides Sales by Application (2017-2028)
6.2.2 North America Oral Proteins and Peptides Revenue by Application (2017-2028)
6.3 North America Oral Proteins and Peptides Market Size by Country
6.3.1 North America Oral Proteins and Peptides Sales by Country (2017-2028)
6.3.2 North America Oral Proteins and Peptides Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oral Proteins and Peptides Market Size by Type
7.1.1 Europe Oral Proteins and Peptides Sales by Type (2017-2028)
7.1.2 Europe Oral Proteins and Peptides Revenue by Type (2017-2028)
7.2 Europe Oral Proteins and Peptides Market Size by Application
7.2.1 Europe Oral Proteins and Peptides Sales by Application (2017-2028)
7.2.2 Europe Oral Proteins and Peptides Revenue by Application (2017-2028)
7.3 Europe Oral Proteins and Peptides Market Size by Country
7.3.1 Europe Oral Proteins and Peptides Sales by Country (2017-2028)
7.3.2 Europe Oral Proteins and Peptides Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Proteins and Peptides Market Size by Type
8.1.1 Asia Pacific Oral Proteins and Peptides Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Proteins and Peptides Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Proteins and Peptides Market Size by Application
8.2.1 Asia Pacific Oral Proteins and Peptides Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Proteins and Peptides Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Proteins and Peptides Market Size by Region
8.3.1 Asia Pacific Oral Proteins and Peptides Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Proteins and Peptides Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oral Proteins and Peptides Market Size by Type
9.1.1 Latin America Oral Proteins and Peptides Sales by Type (2017-2028)
9.1.2 Latin America Oral Proteins and Peptides Revenue by Type (2017-2028)
9.2 Latin America Oral Proteins and Peptides Market Size by Application
9.2.1 Latin America Oral Proteins and Peptides Sales by Application (2017-2028)
9.2.2 Latin America Oral Proteins and Peptides Revenue by Application (2017-2028)
9.3 Latin America Oral Proteins and Peptides Market Size by Country
9.3.1 Latin America Oral Proteins and Peptides Sales by Country (2017-2028)
9.3.2 Latin America Oral Proteins and Peptides Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Proteins and Peptides Market Size by Type
10.1.1 Middle East and Africa Oral Proteins and Peptides Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Proteins and Peptides Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Proteins and Peptides Market Size by Application
10.2.1 Middle East and Africa Oral Proteins and Peptides Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Proteins and Peptides Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Proteins and Peptides Market Size by Country
10.3.1 Middle East and Africa Oral Proteins and Peptides Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Overview
11.3.3 Biocon Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biocon Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biocon Recent Developments
11.4 Generex Biotechnology
11.4.1 Generex Biotechnology Corporation Information
11.4.2 Generex Biotechnology Overview
11.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Generex Biotechnology Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Generex Biotechnology Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novo Nordisk Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novo Nordisk Recent Developments
11.6 Synergy Pharmaceuticals
11.6.1 Synergy Pharmaceuticals Corporation Information
11.6.2 Synergy Pharmaceuticals Overview
11.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Synergy Pharmaceuticals Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Synergy Pharmaceuticals Recent Developments
11.7 Tarsa Therapeutics
11.7.1 Tarsa Therapeutics Corporation Information
11.7.2 Tarsa Therapeutics Overview
11.7.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Tarsa Therapeutics Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tarsa Therapeutics Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Hoffmann-La Roche
11.9.1 Hoffmann-La Roche Corporation Information
11.9.2 Hoffmann-La Roche Overview
11.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hoffmann-La Roche Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hoffmann-La Roche Recent Developments
11.10 Synthetic Biologics
11.10.1 Synthetic Biologics Corporation Information
11.10.2 Synthetic Biologics Overview
11.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Synthetic Biologics Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Synthetic Biologics Recent Developments
11.11 Hovione
11.11.1 Hovione Corporation Information
11.11.2 Hovione Overview
11.11.3 Hovione Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hovione Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hovione Recent Developments
11.12 Novartis
11.12.1 Novartis Corporation Information
11.12.2 Novartis Overview
11.12.3 Novartis Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Novartis Oral Proteins and Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Proteins and Peptides Industry Chain Analysis
12.2 Oral Proteins and Peptides Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Proteins and Peptides Production Mode & Process
12.4 Oral Proteins and Peptides Sales and Marketing
12.4.1 Oral Proteins and Peptides Sales Channels
12.4.2 Oral Proteins and Peptides Distributors
12.5 Oral Proteins and Peptides Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Proteins and Peptides Industry Trends
13.2 Oral Proteins and Peptides Market Drivers
13.3 Oral Proteins and Peptides Market Challenges
13.4 Oral Proteins and Peptides Market Restraints
14 Key Findings in The Global Oral Proteins and Peptides Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer